Author(s):
Anuradha Prajapati, Patel Mehulkumar Pramodbhai, Shruti Jagdish Patel, Soniya Remeshing Sharan, Abhishek Shivshankar Shukla, Kriti Rajesh Singh, Shailesh Luhar, Sachin Narkhede
Email(s):
anupatel03@gmail.com
DOI:
10.52711/0975-4377.2025.00013 
Address:
Anuradha Prajapati*, Patel Mehulkumar Pramodbhai, Shruti Jagdish Patel, Soniya Remeshing Sharan, Abhishek Shivshankar Shukla, Kriti Rajesh Singh, Shailesh Luhar, Sachin Narkhede
Department of Pharmaceutics, Smt. B.N.B. Swaminarayan Pharmacy College, Salvav, Vapi, Gujarat, India 396191.
*Corresponding Author
Published In:
Volume - 17,
Issue - 2,
Year - 2025
ABSTRACT:
The purpose of this study was to develop and evaluate a sublingual tablet of lercanidipine hydrochloride for the direct compression method of treating hypertension by using a solid dispersion technique. The dihydropyridine calcium-channel blocker lercanidipine Hydrochloride is used to treat hypertension, Prinz metal’s variant angina, and chronic stable angina pectoris. It can be administered alone or in combination with an angiotensin-converting enzyme inhibitor. The biological half-life of lercanidipine hydrochloride is 8–10hours, and its duration of action is up to 24hours. Because of its first pass metabolism, lercanidipine hydrochloride has a less than 10% oral bioavailability. BCS class II was applied to lercanidipine hydrochloride due to its high permeability and poor solubility. The aforementioned features and attributes render Lercanidipine Hydrochloride a fitting contender for a sublingual tablet created by robust dispersion and integrating Gelucire 50/13. When compared to pure lercanidipine Hydrochloride, the solubility is high when Gelucire 50/13 was used at the highest concentration. This is the first attempt to improve the solubility of pure lercanidipine HCl free base by the use of various solid dispersion methods, including solvent evaporation, fusion, and physical mixing. Lercanidipine HCl kneading solid dispersion, made with Gelucire 50/13 (1:1)., The prepared lercanidipine HCl sublingual tablets prevent first pass metabolism, avoid swallowing-related issues, particularly in elderly patients, and enhance solubility. The tablet disintegrated in 50 seconds, according to the results. Similarly, a dissolution study conducted in vitro revealed 96.68% drug release in 10 minutes. The prepared lercanidipine HCl sublingual tablets containing a complex with Gelucire 50/13 solid dispersion were found to significantly improve patient compliance and bioavailability.
Cite this article:
Anuradha Prajapati, Patel Mehulkumar Pramodbhai, Shruti Jagdish Patel, Soniya Remeshing Sharan, Abhishek Shivshankar Shukla, Kriti Rajesh Singh, Shailesh Luhar, Sachin Narkhede. Development and Evaluation of Sublingual Tablet of Lercanidipine by Solid Dispersion Method. Research Journal of Pharmaceutical Dosage Forms and Technology. 2025; 17(2):91-6. doi: 10.52711/0975-4377.2025.00013
Cite(Electronic):
Anuradha Prajapati, Patel Mehulkumar Pramodbhai, Shruti Jagdish Patel, Soniya Remeshing Sharan, Abhishek Shivshankar Shukla, Kriti Rajesh Singh, Shailesh Luhar, Sachin Narkhede. Development and Evaluation of Sublingual Tablet of Lercanidipine by Solid Dispersion Method. Research Journal of Pharmaceutical Dosage Forms and Technology. 2025; 17(2):91-6. doi: 10.52711/0975-4377.2025.00013 Available on: https://rjpdft.com/AbstractView.aspx?PID=2025-17-2-1
REFERENCES:
1. Nozawa, Y., Mizumoto, T., and Higashide, F. Improving dissolution rate of practically insoluble drug kitasamycin by forcibly roll mixing with additives. Pharm. Ind. 1986; 8: 967-969.
2. Hancock, B. C., Shamblin, S. L., and Zografi, G. Molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures. Pharmaceutical Research. 1995; 12: 799-806.
3. Yang, M., Li, J., Kathrin, R. J., Gryczke, A., and Asgarzadeh, F. A systematic and predictive approach for formulation development of poorly soluble drugs via solid dispersion. Evonik Degussa Corp. Pharma Polymers, USA.
4. Kolter, K., Karl, M., Nalawade, S., and Rottmann, N. Hot-melt extrusion with BASF Pharma Polymers extrusion compendium. BASF The Chemical Company. 2010
5. Prodduturi, S., Urman, K. L., Otaigbe, J. U., and Repka, M. A. Stabilization of hot-melt extrusion formulations containing solid solutions using polymer blends. AAPS PharmSciTech. 2007; 8(2): E1-E10.
6. Shinde, A. J. Solubilization of poorly soluble drugs: A review. Pharmainfo.net. 2007; 3.
7. Pinnamaneni, S., Das, N. G., and Das, S. K. Formulation approaches for orally administered poorly soluble drugs. Pharmazie. 2002; 57: 291-300.
8. Papageorgiou, G. Z., et al. Effect of physical state and particle size distribution on dissolution enhancement of Nimodipine/PEG solid dispersions prepared by melt mixing and solvent evaporation. AAPS Journal. 2006; 8(4): E623-E631.
9. Homayouni, A., Sadeghi, F., Nokhodchi, A., Varshosaz, J., and Afrasiabi Garekani, H. Preparation and characterization of Celecoxib dispersions in Soluplus®: Comparison of spray drying and conventional methods. Iranian Journal of Pharmaceutical Research. 2015; 14(1): 35-50.
10. Mendiratta, C., Kadam, V., and Pokharkar, V. Lansoprazole solid dispersion using a novel amphiphilic polymer Soluplus®. Journal of Chemical and Pharmaceutical Research. 2011; 3(6): 536-543.
11. Homayouni, A., Sadeghi, F., Varshosaz, J., Afrasiabi Garekani, H., and Nokhodchi, A. Promising dissolution enhancement effect of Soluplus® on crystallized Celecoxib obtained through antisolvent precipitation and high-pressure homogenization techniques. Colloids and Surfaces B: Biointerfaces.
12. Varma, M. M., and Kumar, P. S. Formulation and evaluation of Atorvastatin tablets containing PVP-K30 and Hydroxypropyl-β-cyclodextrin solid dispersion. International Journal of Pharmaceutical Sciences and Nanotechnology. 2012; 5.
13. Kumar, C. S., Ratna, J. V., Aditya, P., et al. Formulation and evaluation of fast dissolving tablets of paracetamol using oats powder. International Journal of Pharmaceutical Science Invention, 2016; 5(3): 7-12.
14. Kumar, K. Solid dispersion: Solubility enhancement technique of poorly water-soluble drug. Journal of Drug Delivery and Therapeutics. 2020; 10(1): 173-177.
15. Ling, H., Luoma, J. T., and Hilleman, D. A review of currently available fenofibrate and fenofibric acid formulations. Cardiology Research. 2013; 4(2): 47-55.
16. Oliveira, M. A., Silva, G. D., and Campos, M. S. Chemical degradation kinetics of fibrates: Bezafibrate, ciprofibrate, and fenofibrate. Brazilian Journal of Pharmaceutical Sciences. 2016; 52(3): 545-553.
17. Raj, A. L., and Kumar, Y. S. Preparation and evaluation of solid dispersion of nebivolol using solvent evaporation method. International Journal of Pharmaceutical Sciences and Drug Research. 2018; 10; 322-328.
18. Duddelli S, Vedavathi T, Kumar A, Rahman Z, Kumar TS. Formulation and in-vitro evaluation of zolmitriptan sublingual tablets. Int J Pharm Bio Sci. 2013; 3(2): 235-246.
19. Aburahma OH, El-Laithy HM, Hamza YE. Preparation and in-vitro/in-vivo characterization of porous sublingual tablets containing a ternary kneaded solid system of vinpocetine with β-cyclodextrin and hydroxy acid. Sci Pharm. 2010; 78: 363-379.
20. Singh SK, Sameer AA. Development and characterization of sublingual tablets of lisinopril. Asia Pac J Trop Biomed. 2012; 2(3): 1711-1719.
21. Nagabandi VK, Sambaraj S. Silica-lipid hybrid microparticles for improved bioavailability of BCS Class IV drugs. Am J Adv Drug Deliv. 2013; 1(5): 663-681.
22. Kansara H, Panola R, Mishra A. Techniques used to enhance bioavailability of BCS Class II drugs: a review. Int J Drug Dev Res. 2015; 7(1): 82-93.
23. Vadlamudi MK, Dhanaraj S. Significance of excipients to enhance the bioavailability of poorly water-soluble drugs in oral solid dosage forms: a review. Mater Sci Eng. 2017; 263: 22-23.
24. Gupta AK, Mittal A, Jha KK. Fast dissolving tablet: a review. Pharma Innov J. 2012; 1(1): 1-8.
25. Bharathi A, Ramakrishna V, Sowjanya K, Deepthi KS. Formulation development and in-vitro evaluation of orally disintegrating tablets of amlodipine besylate. Int J Pharm Res Chem. 2012; 2(4): 1029-1034.
26. Rathaur H, Kumar M, Jha S, Ram A. Review on sublingual route for systemic drug delivery. Indo Am J Pharm Sci. 2018; 5(1): 453-462.
27. Sahoo S, et al. Formulation and evaluation of sublingual tablet of enalapril maleate by 32 full factorial design. Aegaeum J. 2020; 8(4): 894-910.